An evaluation of drug lag for new drugs approved by the Indian regulator relative to the United States, European Union, and Japanese regulatory agencies: A 15-year analysis (2004–2018)

BACKGROUND: The approval process of every drug regulatory agency differs, and hence, the time required for the approval of a new drug varies. This results in a drug lag and India is no exception to this phenomenon. A drug lag precludes Indian patients from accessing new medicines at the same time as...

Descripción completa

Detalles Bibliográficos
Autores principales: Konwar, Mahanjit, Maurya, Mitesh R., Nishandar, Tushar B., Thatte, Urmila M., Gogtay, Nithya J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323564/
https://www.ncbi.nlm.nih.gov/pubmed/34386381
http://dx.doi.org/10.4103/picr.PICR_99_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323564/
https://www.ncbi.nlm.nih.gov/pubmed/34386381
http://dx.doi.org/10.4103/picr.PICR_99_19

Ejemplares similares